Meloxan (Meloxicam)

Meloxicam works by selectively inhibiting the cyclooxygenase‑2 (COX‑2) enzyme, which is responsible for converting arachidonic acid into prostaglandins. By decreasing prostaglandin synthesis, the drug reduces the inflammatory cascade, pain signaling and fever responses at the site of tissue injury. Its relative COX‑2 selectivity aims to limit gastrointestinal side effects compared with non‑selective NSAIDs.

The exact dosage of Meloxan is determined by the prescribing healthcare professional based on the patient’s condition, severity of symptoms, age, renal and hepatic function, and concomitant medications. Typical adult regimens range from low to moderate daily doses, but the prescriber will tailor the amount and frequency to achieve optimal therapeutic effect while minimizing risk.

Safety data for meloxicam in pregnancy and lactation are limited. It is generally advised to avoid use during the first trimester and throughout pregnancy unless the potential benefit justifies the potential risk to the fetus. Likewise, breastfeeding mothers should consult their physician, as meloxicam may be excreted in breast milk and could affect the infant.

To order Meloxan from GNH India, submit an enquiry on the product page at gnhindia.com, specifying the required quantity and intended market. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details and any necessary import documentation.

Compared with non‑selective NSAIDs such as ibuprofen or naproxen, meloxicam offers longer once‑daily dosing and a higher affinity for COX‑2, which may reduce gastrointestinal irritation. However, it still carries cardiovascular and renal risks similar to other NSAIDs. Choice of therapy depends on individual patient risk factors, required duration of treatment and clinician preference.

Meloxan tablets should be stored at ambient temperature, below 25 °C, in their original container. Keep the medication away from moisture, direct sunlight and excessive heat. Do not store in bathrooms or near kitchen sinks. Ensure the packaging remains sealed until use to maintain product stability.

Meloxan is taken orally, usually as a whole tablet swallowed with a full glass of water. It can be taken with or without food; however, taking it with food may lessen stomach upset. Patients should follow the dosing schedule prescribed by their healthcare provider and should not split, crush, or chew the tablet unless specifically instructed.

The most serious adverse events linked to meloxicam include gastrointestinal ulceration or bleeding, which can be life‑threatening, major cardiovascular events such as myocardial infarction or stroke, severe skin reactions like Stevens‑Johnson syndrome, and acute renal failure. Patients should be monitored for signs of abdominal pain, blood in stools, chest discomfort, rash or sudden changes in urine output, and seek immediate medical attention if these occur.

Meloxan should not be used by individuals with a known hypersensitivity to meloxicam or other NSAIDs, those with active gastrointestinal ulceration or bleeding, severe heart failure, uncontrolled hypertension, or advanced renal or hepatic impairment. Caution is also advised in patients taking anticoagulants, other NSAIDs, or selective serotonin reuptake inhibitors. Pregnant women, especially in the first trimester, and breastfeeding mothers should avoid the drug unless clearly indicated by a physician.